Abbott India
Abbott India Share Price Chart
Abbott India last traded at ₹25,800.00 (2026-10-13). Over the past month the stock moved +2.2%, three months the stock moved -6.5%, year the stock moved -14.8%. Its closing range over 52 weeks is ₹25,198.45 – ₹30,069.35, with the latest close 14.2% below the high.
Closing prices up to 2026-10-13.
About Abbott India
Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.[1] It was established in 1944.[2]
Abbott Group:[1] The company is a part of Abbott Laboratories, USA which has a presence in 160 countries with leading medical devices, diagnostics, nutrition products, and branded generic medicines.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Abbott India reported sales of ₹1,814.00 crore (+4.4%) and net profit of ₹429.00 crore (+17.2%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 1,814 | 522.00 | 29.00 | 429.00 | 201.66 |
| Mar 2026 | 1,710 | 481.00 | 28.00 | 395.00 | 185.86 |
| Dec 2025 | 1,724 | 463.00 | 27.00 | 376.00 | 176.93 |
| Sep 2025 | 1,757 | 502.00 | 29.00 | 415.00 | 195.43 |
| Jun 2025 | 1,738 | 446.00 | 26.00 | 366.00 | 172.18 |
| Mar 2025 | 1,605 | 429.00 | 27.00 | 367.00 | 172.73 |
| Dec 2024 | 1,614 | 436.00 | 27.00 | 361.00 | 169.78 |
| Sep 2024 | 1,633 | 439.00 | 27.00 | 359.00 | 168.76 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +9.3% | +12.3% | +11.5% | +11.6% | +7.6% | +6.8% | +6.5% | +4.4% |
| Operating profit growth | +15.2% | +12.4% | +30.0% | +14.1% | +14.4% | +6.2% | +12.1% | +17.0% |
| Net profit growth | +14.7% | +16.1% | +27.9% | +11.6% | +15.6% | +4.2% | +7.6% | +17.2% |
| EPS growth | +14.6% | +16.0% | +27.9% | +11.5% | +15.8% | +4.2% | +7.6% | +17.1% |
| OPM % | 27.0% | 27.0% | 27.0% | 26.0% | 29.0% | 27.0% | 28.0% | 29.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Abbott India reported sales of ₹6,929.00 crore (+8.1%) and net profit of ₹1,552.00 crore (+9.8%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 6,929 | 1,892 | 27.00 | 1,552 | 730.39 |
| Mar 2025 | 6,409 | 1,695 | 26.00 | 1,414 | 665.64 |
| Mar 2024 | 5,849 | 1,453 | 25.00 | 1,201 | 565.30 |
| Mar 2023 | 5,349 | 1,206 | 23.00 | 949.00 | 446.80 |
| Mar 2022 | 4,913 | 1,082 | 22.00 | 799.00 | 375.87 |
| Mar 2021 | 4,310 | 922.00 | 21.00 | 691.00 | 325.04 |
| Mar 2020 | 4,093 | 757.00 | 18.00 | 593.00 | 279.04 |
| Mar 2019 | 3,679 | 605.00 | 16.00 | 450.00 | 211.93 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +11.6% | +11.3% | +5.3% | +14.0% | +8.9% | +9.3% | +9.6% | +8.1% |
| Operating profit growth | +15.2% | +25.1% | +21.8% | +17.4% | +11.5% | +20.5% | +16.7% | +11.6% |
| Net profit growth | +12.2% | +31.8% | +16.5% | +15.6% | +18.8% | +26.6% | +17.7% | +9.8% |
| EPS growth | +12.2% | +31.7% | +16.5% | +15.6% | +18.9% | +26.5% | +17.7% | +9.7% |
| OPM % | 16.0% | 18.0% | 21.0% | 22.0% | 23.0% | 25.0% | 26.0% | 27.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Abbott India.
Get Free AI Stock Analysis FREE →Latest News
-
Abbott India accepts resignation of Company Secretary Sangeeta Shetty - scanx.trade
-
Abbott India accepts resignation of Company Secretary Sangeeta Shetty - scanx.trade
-
Trump's tariff policy: Abbott India, Ajanta Pharma to Alembic — pharma stocks crash up to 4%
-
Dividends, bonus issues, stock splits this week: Bharti Airtel, Hero MotoCorp, Info Edge, Pidilite, Divi's Labs, Abbott India, others in focus - Upstox
-
Abbott India Ltd. Faces Bearish Momentum Amid Technical Downgrade
-
Abbott India Limited Issues Postal Ballot Notice for Appointment of Mr. James Wenner and Mr. Neeraj Jain to Its Board - scanx.trade
-
Abbott India clocks PAT of Rs 394.93 crore in March'26 quarter - Business Standard
-
Abbott India FY26: Net Profit Rs. 1,552.02 Cr, Declares Rs. 656 Dividend - scanx.trade
-
Abbott India Ltd Latest Corporate Announcements, Abbotindia Latest Company News - BSE
-
Q4 results: Canara Bank, JSW Energy, Indian Hotels Company, UPL, Abbott India, PVR Inox, others to post earnings on May 11 - Upstox
Frequently Asked Questions
What is the share price of Abbott India today?
Abbott India shares were last quoted at ₹25,800.00 (-0.8% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Abbott India?
Abbott India has a price-to-earnings (P/E) ratio of 35.22 and a price-to-book (P/B) ratio of 10.93. The industry P/E is 52.82.
What is the 52-week high and low of Abbott India?
The 52-week high of Abbott India is ₹30,598.00 and the 52-week low is ₹25,140.50.
What is the market cap of Abbott India?
The market capitalisation of Abbott India is about ₹56,860.69 crore.
How did Abbott India perform in its latest quarterly results?
In the latest quarter (Jun 2026), Abbott India reported sales of ₹1,814.00 crore (+4.4%) and net profit of ₹429.00 crore (+17.2%), compared with the same quarter last year.
Is Abbott India a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Abbott India has a 3-year ROE of 35.00%, 3-year profit growth of 18.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Abbott India?
Promoters hold about 74.99% of Abbott India.
Which sector does Abbott India belong to?
Abbott India belongs to the Pharmaceuticals & Drugs sector.